Angiodynamics (ANGO) Gains from Investment Securities (2010 - 2026)
Angiodynamics (ANGO) reported Gains from Investment Securities of -$1.0 million for Q1 2026, down 664.97% on a YoY basis from $177000.0 in Q1 2025, and down 323.71% quarter-over-quarter from $447000.0 in Q4 2025.
Angiodynamics (ANGO) Gains from Investment Securities (2010 - 2026) Analysis & Trends
Angiodynamics has reported Gains from Investment Securities for 17 years, with the latest figure at -$1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 664.97% year-over-year to -$1.0 million; the trailing twelve-month figure through Feb 2026 stood at -$603000.0 (down 1139.66% YoY), and the FY2025 full-year result was $272000.0, changed N/A from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$1.0 million, down from $447000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $2.0 million in Q2 2023, with the low at -$1.0 million in Q1 2026.
- Historically, Gains from Investment Securities has averaged $320866.7 across 5 years, with a median of $177000.0 in 2025.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities surged 59350.0% — and 2026, when it slumped 664.97%.
- Angiodynamics' Gains from Investment Securities stood at $1.6 million in 2022, then plunged by 92.16% to $129000.0 in 2023, then sank by 192.25% to -$119000.0 in 2024, then surged by 475.63% to $447000.0 in 2025, then plunged by 323.71% to -$1.0 million in 2026.
- The last three Gains from Investment Securities figures came in at -$1.0 million (Q1 2026), $447000.0 (Q4 2025), and -$264000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.00 Mn |
| Feb 28, 2026 | -1.00 Mn |
| Nov 30, 2025 | 447,000.00 |
| Nov 30, 2025 | 447,000.00 |
| Aug 31, 2025 | -264,000.00 |
| Aug 31, 2025 | -264,000.00 |
| May 31, 2025 | 214,000.00 |
| May 31, 2025 | 214,000.00 |
| Feb 28, 2025 | 177,000.00 |
| Feb 28, 2025 | 177,000.00 |
| Nov 30, 2024 | -119,000.00 |
| Nov 30, 2024 | -119,000.00 |
| Feb 29, 2024 | -138,000.00 |
| Feb 29, 2024 | -138,000.00 |
| Nov 30, 2023 | 129,000.00 |
| Nov 30, 2023 | 129,000.00 |
| Aug 31, 2023 | 9,000.00 |
| Aug 31, 2023 | 9,000.00 |
| May 31, 2023 | 2.00 Mn |
| May 31, 2023 | 2.00 Mn |